News

Speclipse, Inc., a World leading LIPS and A.I. based medical diagnostic company and the developer of the Spectra-Scope, providing instant, scar-free but highly accurate diagnosis for all types of skin cancer, announced the company presented accuracy and clinical efficacy of Specta-Scope at 15th EADO congress, Paris, France.
​
At the congress,” “Accuracy assessment of a real-time skin cancer diagnostic device based on laser spectroscopy and deep learning algorithm using aesthetic lasers,”, a peer reviewed paper was adopted by the congress.

Speclipse, Inc., a World leading LIPS and A.I. based medical diagnostic company and the developer of the Spectra-Scope, providing instant, scar-free but highly accurate diagnosis for all types of skin cancer, announced the company presented Spectra-Scope at 17th World Congress on Cancers of the Skin, Sydney, Australia.

At the congress,” Dr. Saleem Loghdey, Dermatologist and Mohs Surgery, MBChB, FC Derm (SA), CCST, FACD in Miranda, NSW presented “Real-time, non-invasive, in vivo skin cancer diagnostics based on laser spectroscopy and machine learning algorithms.”

Speclipse, Inc., a World leading LIPS and A.I. based medical diagnostic company and the developer of the Spectra-Scope, providing instant, scar-free but highly accurate diagnosis for all types of skin cancer, announced the company was awarded as Top 10 dermatology solution company in 2018 along with Alma and CUTERA by MedTech Outlook.